New era of Indian Pharmaceutical industry is going to begin. Major regulatory pharmaceutical companies are under USFDA alert. Repeated/similar observation are reported against data integrity and GMP practices. Now a day’s process are dependent on the human being, however transition from human to automation is very high. But it is not like that automation can […]

Read More »